Region Hovedstaden — Sponsor Intelligence | 38 EU Trials

Filter these 38 trials by condition, phase, country and more.

Open in Search →

38 Registered trials

23 Recruiting

7 Completed trials

6 Countries active

91 Unique IMPs

100% Results reported

Phase II

Phase IV

Phase III: 1 Phase II/III: 3 Phase II: 14 Phase I/II: 2 Phase III/IV: 2 Phase IV: 12 Phase I: 1 Phase I (Other): 3

100%

7 of 7 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Angiosarcoma 1 Obesity 1 Childhood asthma 1 Basal cell carcinoma 1

Top IMPs

SEMAGLUTIDE 4 SODIUM CHLORIDE 4 IPILIMUMAB 3 NIVOLUMAB 3 PEMBROLIZUMAB 3 DENOSUMAB 2 ACETAZOLAMIDE 1 ALECTINIB HYDROCHLORIDE 1 AMOXICILLIN, CLAVULANIC ACID 1 AMPICILLIN 1 BLEOMYCIN 1 CABOZANTINIB 1

All trials — page 2

38 total

Can a single dose of psilocybin reduce alcohol intake in patients with alcohol use disorder? Recruiting

2024-517497-17-01 Phase I/II 1 country DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL
A phase 2 trial on propranolol in combination with pembrolizumab in advanced Angiosarcoma and Undifferentiated Pleomorphic Sarcoma Recruiting

2024-513727-16-00 Phase II 3 countries PEMBROLIZUMAB
Does Tranexamic acid, a medicine used in treating and preventing bleeding problems, reduce the blood loos when it is injected directly into … Recruiting

2024-517398-26-01 Phase II 1 country TRANEXAMIC ACID
Electrochemotherapy versus standard radiotherapy for the treatment of basal cell carcinoma Recruiting

2024-519066-49-01 Phase IV 1 country BLEOMYCIN
The DENOCHARCOT trial. Efficacy of treatment with DENOsumab of an acute CHARCOT foot in patients with diabetes. A multicenter, double-blind,… Recruiting

2024-515365-34-00 Phase IV 1 country DENOSUMAB
Goal directed fluid removal in critically ill patients with fluid overload Recruiting

2024-512186-14-00 Phase IV 5 countries FUROSEMIDE PH. EUR.
Efficacy of immunotherapy in melanoma patients with brain metastases treated with steroids. The MEMBRAINS trial Recruiting

2024-516585-11-00 Phase II 1 country IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB
Safety and potential efficacy of combining immunotherapy with chemotherapy and radiation for treatment of borderline resectable, nonresectab… Ended

2024-518173-34-00 Phase I/II 1 country IPILIMUMAB; NIVOLUMAB; PACLITAXEL ALBUMIN-BOUND
NT-NOA - Novel Treatment of some men with Non-Obstructive Azoospermia A clinical interventional trial Ended

2024-512996-11-00 Phase II 1 country DENOSUMAB; LETROZOLE
Cannabidiol for treatment of non-affective psychosis and cannabis use Ended

2024-517630-18-00 Phase II/III 1 country CANNABIDIOL; RISPERIDONE
SEMALCO Ended

2023-503371-25-00 Phase II 1 country SEMAGLUTIDE
Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer (CheckVAC) Ended

2024-515966-14-00 Phase I 1 country
A clinical trial on an individualized treatment strategy for patients with metastatic non-clear cell kidney cancer Ended

2024-519070-39-00 Phase II 1 country ALECTINIB HYDROCHLORIDE; CABOZANTINIB; CRIZOTINIB; DABRAFENIB; ERLOTINIB; IMATIN…
A randomized placebo-controlled double-blinded trial of the treatment of MRSA throat carriage with either standard decolonization therapy or… Ended

2024-516377-69-01 Phase IV 1 country

Showing 25–38 of 38 trials

← All sponsors A–Z